Marathon Venture Partners

Marathon Venture Partners is a Beijing-based early-stage fund pursuing a thesis-driven approach to digital health platforms and the consumerization of medical services in the Chinese market. The firm focuses on health IT, healthcare software, and digital health at Series A and Series B, suggesting interest in platforms that combine clinical workflow software with patient-facing services or consumer healthcare access. Limited public information about named partners, specific portfolio commitments, and recent fund vintages is available in English-language sources, so founders should expect to validate the firm’s current investment posture directly.

Check sizes range from 1 million to 5 million dollars at Series A and Series B, sized to underwrite scaling activities such as commercial team build-out, geographic expansion within China, or product line extension. Geography centers on China with Beijing as the operating base, positioning the firm close to major hospitals, regulatory bodies, and the Beijing healthcare technology cluster. Companies operating outside the Chinese market or in capital-intensive biotech and device categories will not align with the thesis.

The approach suits founders building digital health platforms or consumer-leaning healthcare services who want investors fluent in the Chinese consumer healthcare landscape, including evolving payer dynamics, hospital partnerships, and patient acquisition channels. Founders expecting deep biotech regulatory expertise or international syndication leadership should calibrate accordingly. Initial conversations should focus on the company’s commercial traction within Chinese markets, the realism of the consumerization thesis at the company’s particular stage, and what specific operational support Marathon offers beyond capital, particularly around hospital partnerships and downstream syndicate construction.